Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05803928 | Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies | unknown | Phase 1 | 70 | Hua LiOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT05883683 | Molecular Study and Precision Medicine for Colorectal Cancer(MSPM) | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 |
| clinicaltrials |
| NCT06256055 | Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors | unknown | Phase 1 | 24 | UTC Therapeutics Inc.INDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06516445 | SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC | unknown | Phase 2 | 33 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06515964 | China Early Esophageal Cancer Cohort | unknown | — | 1,000 | Changhai HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06512428 | A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 138 | Shanghai Runshi Pharmaceutical Technology Co., LtdINDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06513481 | A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery(E-DISTANCE) | unknown | — | 914 | RenJi HospitalOTHER | 0 | Jul 22, 2024 | clinicaltrials |
| NCT06505486 | GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC | unknown | — | 21 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT05183243 | GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results | unknown | Phase 1 | 68 | Suzhou Genhouse Bio Co., Ltd.OTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06502704 | Bile Acids and Microbiome in Early Colorectal Carcinogenesis | unknown | — | 60 | Vilnius UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT04798820 | The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)(SING) | unknown | N/A | 358 | Samsung Medical CenterOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06497777 | The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer | unknown | — | 30 | National Taiwan University HospitalOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT06499792 | Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy(DPC-RATAP) | unknown | — | 160 | University Hospital, Strasbourg, FranceOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT05389527 | Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma(NeoLeap-HCC) | unknown | Phase 2 | 43 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT06495853 | Prospective Phase II Study on Continuous Circumferential Reinforcement of Laparoscopic Rectal Anastomosis to Prevent Complications | unknown | Phase 2 | 208 | ZHI-ZHONG PANOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT06496438 | Probiotics for Depression in Cancer Patients | unknown | N/A | 270 | Aristotle University Of ThessalonikiOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT06496789 | Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer | unknown | Phase 2 | 35 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT01171300 | Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients | unknown | N/A | 94 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT04278222 | Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) | unknown | Phase 2 | 24 | Shanghai Changzheng HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06387810 | Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer(undetermined) | unknown | Phase 2 | 45 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT04715633 | PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer | unknown | Phase 2 | 53 | Sun Yat-sen UniversityOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT05739045 | Nivolumab Combined With SOX Used in the Perioperative Treatment | unknown | Phase 2 | 46 | Xiangdong ChengOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT06491355 | First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer | unknown | Phase 2 | 72 | Sir Run Run Shaw HospitalOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over(ADAGE) | unknown | Phase 3 | 774 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03760822 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients(SOCRATE) | unknown | Phase 2 | 112 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | unknown | Phase 2 | 107 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04891900 | TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma | unknown | N/A | 25 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 8, 2024 | clinicaltrials |
| NCT06489288 | ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer | unknown | N/A | 2,656 | Xijing HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT04654975 | Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)(METABREC) | unknown | — | 10,000 | Universitaire Ziekenhuizen KU LeuvenOTHER | 6 | Jul 3, 2024 | clinicaltrials |
| NCT05229003 | Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06090656 | Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)(BEST) | unknown | Phase 2 | 88 | Sun Yat-sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06485713 | Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC | unknown | Phase 2 | 200 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05606848 | To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer | unknown | N/A | 350 | Fresenius Kabi Sino-Swed Pharmaceutical Corp. LtdINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06456281 | Multi-omics Model for Pancreatic Cancer Screening Using cfDNA | unknown | — | 480 | Fudan UniversityOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481449 | Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study | unknown | — | 2,600 | Hebei Medical University Fourth HospitalOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481605 | A Novel Adaptive Anastomotic Technique for Left-sided Colonic and Rectal Resection(NOVA) | unknown | N/A | 30 | Istituto Clinico HumanitasOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06482008 | HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 0 | Jul 1, 2024 | clinicaltrials |
| NCT04896684 | Chronic Intestinal Pathologies Analytical Cohort at TouLouse(CAPITOL) | unknown | — | 300 | University Hospital, ToulouseOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT04432857 | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors | unknown | Phase 1 | 63 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 2 | Jun 27, 2024 | clinicaltrials |
| NCT06478810 | Ambulatory Surgery After Hepatectomy: Monitoring by Domomedicine Connected Tools and a Dedicated Nurse.(HEPADOM) | unknown | N/A | 20 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT03774134 | Five Year Oncological Outcome After CME for Sigmoid Colon Cancer | unknown | — | 920 | Nordsjaellands HospitalOTHER | 0 | Jun 26, 2024 | clinicaltrials |
| NCT06326892 | Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery(NOSES) | unknown | — | 350 | Istituto Clinico HumanitasOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475196 | Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC | unknown | — | 90 | Tang-Du HospitalOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475287 | HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 42 | Fudan UniversityOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475417 | Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer | unknown | Phase 2 | 42 | Tang-Du HospitalOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06472063 | Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study(SNAC) | unknown | — | 684 | San Luigi Gonzaga HospitalOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT05444088 | Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 129 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05880992 | Trimodal Prehabilitation in Colorectal Cancer Patients(PrehabCRC) | unknown | N/A | 50 | Jordan LeitchOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06467565 | NALIRIFOX as Induction Therapy in LAPC | unknown | Phase 2 | 20 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 24, 2024source: clinicaltrials